JP2017514856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017514856A5 JP2017514856A5 JP2016566651A JP2016566651A JP2017514856A5 JP 2017514856 A5 JP2017514856 A5 JP 2017514856A5 JP 2016566651 A JP2016566651 A JP 2016566651A JP 2016566651 A JP2016566651 A JP 2016566651A JP 2017514856 A5 JP2017514856 A5 JP 2017514856A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- alkoxy
- independently
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[C@@](C1)C2CC1*C2 Chemical compound C[C@@](C1)C2CC1*C2 0.000 description 9
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461989651P | 2014-05-07 | 2014-05-07 | |
| US61/989,651 | 2014-05-07 | ||
| PCT/US2015/029409 WO2015171722A1 (en) | 2014-05-07 | 2015-05-06 | Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017514856A JP2017514856A (ja) | 2017-06-08 |
| JP2017514856A5 true JP2017514856A5 (https=) | 2018-04-19 |
| JP6483156B2 JP6483156B2 (ja) | 2019-03-13 |
Family
ID=53181359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566651A Active JP6483156B2 (ja) | 2014-05-07 | 2015-05-06 | 糖尿病などの疾患の治療用のピロリジンｇｐｒ４０モジュレータ |
Country Status (33)
| Country | Link |
|---|---|
| US (4) | US9873679B2 (https=) |
| EP (1) | EP3140296B1 (https=) |
| JP (1) | JP6483156B2 (https=) |
| KR (1) | KR102336370B1 (https=) |
| CN (1) | CN106458976B (https=) |
| AR (1) | AR100328A1 (https=) |
| AU (1) | AU2015256120B2 (https=) |
| BR (1) | BR112016024936A2 (https=) |
| CA (1) | CA2948161C (https=) |
| CL (1) | CL2016002809A1 (https=) |
| CY (1) | CY1120340T1 (https=) |
| DK (1) | DK3140296T3 (https=) |
| EA (1) | EA033250B1 (https=) |
| ES (1) | ES2674531T3 (https=) |
| HR (1) | HRP20180641T1 (https=) |
| HU (1) | HUE039288T2 (https=) |
| IL (1) | IL248668B (https=) |
| MA (1) | MA39427B1 (https=) |
| MX (1) | MX378160B (https=) |
| MY (1) | MY181959A (https=) |
| NZ (1) | NZ727146A (https=) |
| PE (1) | PE20161363A1 (https=) |
| PH (1) | PH12016502034B1 (https=) |
| PL (1) | PL3140296T3 (https=) |
| PT (1) | PT3140296T (https=) |
| RS (1) | RS57170B1 (https=) |
| SG (1) | SG11201609170UA (https=) |
| SI (1) | SI3140296T1 (https=) |
| SM (1) | SMT201800342T1 (https=) |
| TN (1) | TN2016000444A1 (https=) |
| TR (1) | TR201809633T4 (https=) |
| TW (1) | TWI659951B (https=) |
| WO (1) | WO2015171722A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2671402T3 (es) * | 2014-05-07 | 2018-06-06 | Bristol-Myers Squibb Company | Moduladores de pirrolidina GPR40 para el tratamiento de enfermedades tales como diabetes |
| EP3140296B1 (en) * | 2014-05-07 | 2018-04-11 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes |
| JP7086942B2 (ja) | 2016-09-12 | 2022-06-20 | インテグラル ヘルス， インコーポレイテッド | Ｇｐｒ１２０モジュレーターとして有用な単環式化合物 |
| WO2018049328A1 (en) | 2016-09-12 | 2018-03-15 | Numerate, Inc. | Bicyclic compounds useful as gpr120 modulators |
| WO2018181847A1 (ja) * | 2017-03-31 | 2018-10-04 | 武田薬品工業株式会社 | 芳香環化合物 |
| BR102018007822A2 (pt) | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| CN110772636B (zh) * | 2017-08-21 | 2021-03-16 | 武汉大学 | Gpr31抑制剂在制备治疗心脏缺血再灌注损伤及相关疾病药物中的应用 |
| CR20200347A (es) | 2018-02-13 | 2020-09-23 | Gilead Sciences Inc | Inhibidores pd-1/pd-l1 |
| TWI712412B (zh) | 2018-04-19 | 2020-12-11 | 美商基利科學股份有限公司 | Pd‐1/pd‐l1抑制劑 |
| SG11202012425QA (en) | 2018-07-13 | 2021-01-28 | Gilead Sciences Inc | Pd-1/pd-l1 inhibitors |
| WO2020086556A1 (en) | 2018-10-24 | 2020-04-30 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| AU2022291768A1 (en) | 2021-06-16 | 2023-11-30 | Celgene Corporation | Azetidinyl compounds comprising a carboxylic acid group for the treatment of neurodegenerative diseases |
| CN116283699B (zh) * | 2023-03-02 | 2025-02-11 | 遵义医科大学 | 一种合成氟烷基取代的吡咯烷的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| CN102639495A (zh) * | 2009-10-06 | 2012-08-15 | 百时美施贵宝公司 | 吡咯烷gpr40调节剂 |
| US7939569B1 (en) * | 2009-12-01 | 2011-05-10 | Hoffmann-La Roche Inc. | Aniline analogs as glycogen synthase activators |
| GB2498976A (en) * | 2012-02-01 | 2013-08-07 | Prosidion Ltd | GPR119 agonists useful in the treatment of type II diabetes |
| EP2880034B1 (en) | 2012-08-01 | 2016-06-22 | Bristol-Myers Squibb Company | Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of p2y1 receptor |
| RS55363B1 (sr) | 2012-11-16 | 2017-03-31 | Bristol Myers Squibb Co | Dihidropirazolni gpr40 modulatori |
| SG11201503562PA (en) | 2012-11-16 | 2015-06-29 | Bristol Myers Squibb Co | Dihydropyrazole gpr40 modulators |
| SG11201503556PA (en) | 2012-11-16 | 2015-06-29 | Bristol Myers Squibb Co | Dihydropyrazole gpr40 modulators |
| CA2891569A1 (en) * | 2012-11-16 | 2014-05-22 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators |
| EP3140296B1 (en) * | 2014-05-07 | 2018-04-11 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes |
| EP3139903B1 (en) | 2014-05-07 | 2019-07-03 | Croma-Pharma Gesellschaft m.b.H. | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| WO2015171757A1 (en) | 2014-05-07 | 2015-11-12 | Bristol-Myers Squibb Company | Pyrrolidine gpr40 modulators |
-
2015
- 2015-05-06 EP EP15723095.4A patent/EP3140296B1/en active Active
- 2015-05-06 SG SG11201609170UA patent/SG11201609170UA/en unknown
- 2015-05-06 ES ES15723095.4T patent/ES2674531T3/es active Active
- 2015-05-06 MA MA39427A patent/MA39427B1/fr unknown
- 2015-05-06 US US14/705,524 patent/US9873679B2/en active Active
- 2015-05-06 PE PE2016002178A patent/PE20161363A1/es unknown
- 2015-05-06 PL PL15723095T patent/PL3140296T3/pl unknown
- 2015-05-06 DK DK15723095.4T patent/DK3140296T3/en active
- 2015-05-06 HU HUE15723095A patent/HUE039288T2/hu unknown
- 2015-05-06 SI SI201530232T patent/SI3140296T1/en unknown
- 2015-05-06 KR KR1020167033863A patent/KR102336370B1/ko active Active
- 2015-05-06 CA CA2948161A patent/CA2948161C/en active Active
- 2015-05-06 SM SM20180342T patent/SMT201800342T1/it unknown
- 2015-05-06 RS RS20180504A patent/RS57170B1/sr unknown
- 2015-05-06 TW TW104114493A patent/TWI659951B/zh active
- 2015-05-06 TN TN2016000444A patent/TN2016000444A1/en unknown
- 2015-05-06 AR ARP150101379A patent/AR100328A1/es unknown
- 2015-05-06 PT PT157230954T patent/PT3140296T/pt unknown
- 2015-05-06 EA EA201692037A patent/EA033250B1/ru not_active IP Right Cessation
- 2015-05-06 WO PCT/US2015/029409 patent/WO2015171722A1/en not_active Ceased
- 2015-05-06 MX MX2016013801A patent/MX378160B/es unknown
- 2015-05-06 MY MYPI2016704054A patent/MY181959A/en unknown
- 2015-05-06 TR TR2018/09633T patent/TR201809633T4/tr unknown
- 2015-05-06 HR HRP20180641TT patent/HRP20180641T1/hr unknown
- 2015-05-06 BR BR112016024936A patent/BR112016024936A2/pt not_active Application Discontinuation
- 2015-05-06 AU AU2015256120A patent/AU2015256120B2/en active Active
- 2015-05-06 JP JP2016566651A patent/JP6483156B2/ja active Active
- 2015-05-06 NZ NZ727146A patent/NZ727146A/en unknown
- 2015-05-06 CN CN201580022579.4A patent/CN106458976B/zh active Active
-
2016
- 2016-10-12 PH PH12016502034A patent/PH12016502034B1/en unknown
- 2016-11-01 IL IL248668A patent/IL248668B/en active IP Right Grant
- 2016-11-07 CL CL2016002809A patent/CL2016002809A1/es unknown
-
2017
- 2017-12-13 US US15/840,198 patent/US20180099949A1/en not_active Abandoned
-
2018
- 2018-05-23 CY CY20181100547T patent/CY1120340T1/el unknown
- 2018-12-06 US US16/211,848 patent/US10717725B2/en active Active
-
2020
- 2020-06-08 US US16/895,058 patent/US20200299267A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017514856A5 (https=) | ||
| JP7664947B2 (ja) | Ｉｌ－１７の調節因子としてのイミダゾリダジン | |
| JP7611278B2 (ja) | 金属酵素阻害剤化合物 | |
| JP6130964B2 (ja) | Ａｐｊ受容体のトリアゾールアゴニスト | |
| JP2018505203A5 (https=) | ||
| AU2014233414B2 (en) | N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP2017508794A5 (https=) | ||
| JP2016516043A5 (https=) | ||
| JP2024514010A (ja) | カルボキシ－ベンズイミダゾールｇｌｐ－１ｒ調節化合物 | |
| JP2016520128A5 (https=) | ||
| JP2015500887A5 (https=) | ||
| RU2016115803A (ru) | Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний | |
| JP2017508795A5 (https=) | ||
| JP2017529389A5 (https=) | ||
| RU2011121567A (ru) | Изоиндолиновые соединения для применения при лечении рака | |
| JP2016526576A5 (https=) | ||
| JP2016525136A5 (https=) | ||
| JP2017514865A5 (https=) | ||
| JP2013518110A (ja) | 疼痛および他の適応症の治療用の医薬組成物 | |
| WO2010122980A1 (ja) | 新規甲状腺ホルモンβ受容体作動薬 | |
| CN105085428B (zh) | 芳杂环类衍生物及其在药物上的应用 | |
| JP2016513696A5 (https=) | ||
| JP2021512114A5 (https=) | ||
| CN112955448A (zh) | 芳环或芳杂环类化合物及其制备方法和医药用途 | |
| CN121895290A (zh) | 哒嗪酮或哒嗪类化合物及其衍生物和药物组合物 |